Join
Live feed
·
INSIDERFilingvia Quantisnow
Verona Pharma plc logo

Director Brady James Aloysius converted options into 24,000 units of Ordinary Shares and sold $10,830 worth of Ordinary Shares (824 units at $13.14) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VRNA· Verona Pharma plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VRNA (Verona Pharma plc) and more on Quantisnow.